Pain Medicine · Clearwater, FL
NPI
1619948429
Since 2006
Specialty
Pain Medicine
Code 208VP0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2250 Drew St
Clearwater, FL, 33765
Phone (727) 724-5631
Groups this clinician bills Medicare through
Medicare paid, 2024
$986K
44,263 services
Medicare patients, 2024
732
Average age 70
Drug cost, 2024
$2.6M
30,463 prescriptions
Company payments, 2025
$1,899
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashraf Hanna was code J0585 (injection, onabotulinumtoxina, 1 unit), 14,776 times for 47 patients. In total Ashraf Hanna billed 44,263 services in 69 codes, and Medicare paid $986K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 14,776 | 47 | $4.98 | $74K |
| J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 6,311 | 31 | $0.02 | $133 |
| J3490 Unclassified drugs | Office | 3,172 | 43 | $0.35 | $1,116 |
| 99214 Office E&M - Established | Office | 2,976 | 628 | $96.16 | $286K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 2,585 | 38 | $0.07 | $183 |
| 96375 Injection Administration | Office | 1,463 | 36 | $12.01 | $18K |
| 99213 Office E&M - Established | Office | 1,159 | 464 | $72.23 | $84K |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 1,015 | 31 | $0.10 | $102 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 885 | 28 | $0.37 | $329 |
| 80305 Drug Tests | Office | 740 | 454 | $12.10 | $8,953 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 735 | 448 | $193.81 | $142K |
| 96366 Intravenous Infusion, Hydration | Office | 731 | 37 | $15.76 | $12K |
| 20550 Musculoskeletal | Office | 722 | 210 | $47.14 | $34K |
| 96130 Behavioral Health Services | Office | 702 | 399 | $95.85 | $67K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 679 | 278 | $5.48 | $3,723 |
By year: 2022 $1.0M for 68,583 services; 2023 $950K for 49,855 services; 2024 $986K for 44,263 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 740 | 454 | $12.10 | $8,953 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 735 | 448 | $193.81 | $142K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 47 | 25 | $183.25 | $8,613 |
Medicare prescription drug claims, 2024
In 2024, the drug Ashraf Hanna prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 3,623 prescriptions and refills. In total Ashraf Hanna wrote 30,463 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,623 | 3,624 | 500 | $140K |
| Oxycodone Hcl Generic | 3,064 | 3,064 | 375 | $61K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,789 | 2,790 | 466 | $77K |
| Morphine Sulfate Er Morphine Sulfate | 2,436 | 2,436 | 300 | $81K |
| Gabapentin Generic | 2,267 | 2,641 | 401 | $30K |
| Pregabalin Generic | 1,544 | 1,645 | 336 | $30K |
| Cyclobenzaprine Hcl Generic | 1,219 | 1,323 | 247 | $13K |
| Baclofen Generic | 939 | 1,163 | 222 | $14K |
| Meloxicam Generic | 905 | 1,220 | 199 | $2,778 |
| Tizanidine Hcl Generic | 882 | 1,102 | 193 | $12K |
| Naloxone Hcl Generic | 824 | 824 | 738 | $53K |
| Xtampza Er Oxycodone Myristate | 699 | 699 | 113 | $489K |
| Morphine Sulfate Generic | 656 | 656 | 86 | $22K |
| Tramadol Hcl Generic | 566 | 568 | 146 | $5,862 |
| Fentanyl Generic | 514 | 515 | 57 | $56K |
Brand drugs: 2,734 claims; generic drugs: 27,729 claims; opioid claims: 15,375.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashraf Hanna $1,899 ($1,899 in general payments such as food, travel and fees) from 16 companies. The largest payer was Collegium Pharmaceutical, Inc. with $293.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 21 | $293 |
| Pfizer Inc. PFE | 11 | $290 |
| Boston Scientific Corporation BSX | 4 | $191 |
| Axsome Therapeutics, Inc. AXSM | 4 | $188 |
| Abbvie Inc. ABBV | 9 | $179 |
| Scilex Pharmaceuticals Inc. | 8 | $177 |
| Abbott Laboratories ABT | 3 | $159 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $125 |
| Impel Pharmaceuticals LLC | 5 | $99.92 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $60.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.